[pmontra]

According to the article 500,000 doses are the production of July, and 90% of August and September. Three full months would be 500,000 / 2.80 * 3 = 535,714 doses. A full treatment is made of six doses. There are 89,285 treatments in there. Less than 30,000 per month. Too bad for the rest of the world that all of them will happen in the USA but they are way too few to matter globally. Split them proportionally with the population and how many of them are going to be assigned to any European country? Maybe we need a x10 in the production or more. Better, local production, which I understand is neither quick nor easy.

[s1artibartfast]

Gilead is not the only producer because it has licensed numerous other companies to manufacture the product.

See this post:

https://news.ycombinator.com/item?id=23700736

[watwut]

> Better, local production, which I understand is neither quick nor easy.

There is patent. So, it is not legal unless countries change patent law.

[abdusco]

> Better, local production, which I understand is neither quick nor easy.

I know nothing about the patent law, but according to the article, drug is patented. Assuming the process is not open-source, I'd argue that other countries would be looking for alternative vaccinations.

From the article:

> The drug, which was trialed in the Ebola epidemic but failed to work as expected, is under patent to Gilead, which means no other company in wealthy countries can make it. The cost is around $3,200 per treatment of six doses, according to the US government statement.